Financials

News Ideas Discussions Technicals Forecast Seasonals Options

CRSP fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of CRISPR Therapeutics AG

Total assets of CRSP for Q2 25 is 2.03 B USD, 6.30% less than the previous Q1 25. And total liabilities decreased by 5.45% in Q2 25 to 318.59 M USD.

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD